JOURNAL OF CHEMICAL RESEARCH 2012 405
ArH), 7.00 (s, 2H, ArH), 6.95 (s, 2H, ArH), 5.07 (s, 2H, OCH2Ar),
4.28 (d, J = 12.8Hz, 2H,ArCH2Ar), 4.20 (d, J = 13.6Hz, 2H,ArCH2Ar),
3.40 (d, J = 13.2Hz, 4H, ArCH2Ar), 1.19 (s, 36H, C(CH3)3); 13C NMR
(CDCl3) δ 148.6, 147.9, 147.1, 143.1, 142.6, 137.6, 134.8, 133.0,
130.4, 127.8, 127.4, 127.1, 126.2, 125.4, 125.3, 125.2, 94.6, 78.0,
34.1, 33.8, 33.7, 32.8, 32.2, 31.3, 31.1; MS(ESI): m/z (%) = 882
(M+ + NH4, 100).
δ 7.45 (d, J = 6.8 Hz, 2H, ArH), 7.27–7.18 (m, 13H, ArH), 7.06 (s,
2H, ArH), 6.97 (s, 2H, ArH), 6.56 (d, J = 2.4 Hz, 2H, ArH), 6.49 (d,
J = 2.4 Hz, 2H, ArH), 6.32 (s, 1H, OH), 4.92 (s, 2H, OCH2Ar), 4.65
(d, J = 11.6 Hz, 2H, OCH2Ar), 4.58 (d, J = 11.6 Hz, 2H, OCH2Ar),
4.17 (d, J = 13.6 Hz, 2H, ArCH2Ar), 4.13 (d, J = 12.8 Hz, 2H,
ArCH2Ar), 3.03 (d, J = 13.2Hz, 2H, ArCH2Ar), 2.96 (d, J = 12.8 Hz,
2H, ArCH2Ar), 1.31 (s, 9H, C(CH3)3), 1.29 (s, 9H, C(CH3)3), 0.83 (s,
18H, C(CH3)3); 13C NMR (CDCl3) δ 153.1, 150.8, 150.7, 145.4, 145.2,
140.9, 138.3, 137.3, 135.6, 132.4, 132.1, 129.2, 128.6, 128.5, 128.0,
127.6, 127.4, 127.0, 125.3, 124.8, 77.5, 76.0, 34.2, 33.9, 33.8, 31.84,
31.79, 31.7, 31.4, 31.1; MS(ESI): m/z (%) = 827(100), 917 (M− – 1,
70).
25-(4-Methylbenzyloxy)-26,27,28-trihydroxy-p-t-butylcalix[4]-
arene (3c): White needles; m.p. 129.2–131.0 °C; IR vmax = 3332, 3049,
1
2960, 2868, 1484, 1362, 871, 783 cm−1; H NMR (CDCl3) δ 10.00
(s, 1H, OH), 9.39 (s, 2H, OH), 7.58 (d, J = 8.0 Hz, 2H, ArH), 7.28 (d,
J = 7.6 Hz, 2H, ArH), 7.10 (s, 2H, ArH), 7.03 (d, J = 2.4 Hz, 2H, ArH),
7.01 (s, 2H,ArH), 6.95 (d, J = 2.0 Hz, 2H,ArH), 5.13 (s, 2H, OCH2Ar),
4.33 (d, J = 12.8 Hz, 2H, ArCH2Ar), 4.22 (d, J = 13.6 Hz, 2H,
ArCH2Ar), 3.39 (d, J = 13.2 Hz, 4H, ArCH2Ar), 2.42 (s, 3H, CH3),
1.22 (s, 18H, C(CH3)3), 1.21 (s, 18H, C(CH3)3); 13C NMR (CDCl3)
δ 149.2, 148.3, 148.0, 147.6, 143.3, 142.8, 138.6, 133.5, 132.5, 129.4,
129.1, 128.1, 127.9, 127.5, 126.3, 125.5, 125.4, 79.1, 34.4, 34.1, 34.0,
33.1, 32.6, 31.6, 31.4, 21.5; MS(ESI): m/z (%) = 751 (M− – 1, 100);
HRMS-ESI: Calcd for C52H68NO4 (M+NH4)+: 770.5148; found:
770.5113.
25,26,27-Tris(4-iodobenzyloxy)-28-hydroxy-p-t-butylcalix[4]arene
(3h): White solid; m.p. 217.2–219.1 °C; IR vmax = 3446, 3042, 2959,
l
2866, 1483, 1197, 870, 801 cm−1; H NMR (CDCl3) δ 7.54 (d, J =
8.4 Hz, 6H, ArH), 7.36 (d, J = 8.0 Hz, 2H, ArH), 7.12 (s, 2H, ArH),
7.00 (s, 2H, ArH), 6.87 (d, J = 8.4 Hz, 4H, ArH), 6.57 (d, J = 2.4 Hz,
2H, ArH), 6.48 (d, J = 2.4 Hz, 2H, ArH), 6.22 (s, 1H, OH), 4.76 (s, 2H,
OCH2Ar), 4.53 (d, J = 11.6 Hz, 2H, OCH2Ar), 4.43 (d, J = 11.6 Hz,
2H, OCH2Ar), 4.10 (d, J = 4.0 Hz, 2H, ArCH2Ar), 4.07 (d, J = 4.8 Hz,
2H, ArCH2Ar), 3.08 (d, J = 13.2 Hz, 2H, ArCH2Ar), 3.03 (d, J =
12.4 Hz, 2H, ArCH2Ar); 1.33 (s, 9H, C(CH3)3), 1.30 (s, 9H, C(CH3)3),
0.82 (s, 18H, C(CH3)3); 13C NMR (CDCl3) δ 152.6, 150.1, 145.7,
145.2, 140.8, 137.4, 136.9, 136.1, 136.0, 135.1, 131.8, 131.6, 130.4,
129.9, 127.8, 125.2, 124.6, 124.5, 93.5, 92.4, 76.8, 74.9, 33.9, 33.6,
33.5, 31.52, 31.46, 31.3, 30.8; MS(ESI): m/z (%) = 1314 (M+ + NH4,
100); HRMS-ESI: Calcd for C65H75I3NO4 (M+NH4)+: 1314.2830;
found: 1314.2782.
25,26,27-Tris(4-methylbenzyloxy)-28-hydroxy-p-t-butylcalix[4]-
arene (3i): White needles; m.p. 184.2–186.1 °C; IR vmax = 3414, 3044,
2948, 2865, 1480, 1198, 870, 802 cm−1; 1H NMR (CDCl3) δ 7.35 (d,
J = 8.0 Hz, 2H, ArH), 7.14 (d, J = 8.0 Hz, 4H, ArH), 7.05(s, 2H, ArH),
7.04 (d, J = 7.6 Hz, 4H, ArH), 6.99 (d, J = 8.0 Hz, 2H, ArH), 6.96 (s,
2H, ArH), 6.55 (d, J = 2.4 Hz, 2H, ArH), 6.48 (d, J = 2.4 Hz, 2H,
ArH), 6.34 (s, 1H, OH), 4.89 (s, 2H, OCH2Ar), 4.60 (d, J = 11.6 Hz,
2H, OCH2Ar), 4.55 (d, J = 11.2 Hz, 2H, OCH2Ar), 4.16 (d, J = 1.2 Hz,
2H, ArCH2Ar), 4.13 (d, J = 2.0 Hz, 2H, ArCH2Ar), 3.01 (d, J =
13.2 Hz, 2H, ArCH2Ar), 2.97 (d, J = 12.8 Hz, 2H, ArCH2Ar), 2.33 (s,
3H, CH3), 2.32 (s, 6H, CH3), 1.31 (s, 9H, C(CH3)3), 1.28(s, 9H,
C(CH3)3), 0.83 (s, 18H, C(CH3)3); 13C NMR (CDCl3) δ 153.2, 150.9,
150.7, 145.2, 145.0, 140.8, 137.1, 136.2, 135.6, 135.4, 134.4, 132.4,
132.1, 129.2, 128.7, 128.1, 125.3, 124.7, 77.4, 75.8, 34.2, 33.9, 33.8,
31.9, 31.8, 31.5, 31.2, 21.4; MS(ESI): m/z (%) = 983 (M+ + Na, 100);
HRMS-ESI: Calcd for C68H84NO4 (M+NH4)+: 978.6400; found:
978.6405.
Synthesis of di-O-arylmethyl-p-t-butylcalix[4]arenes 3d–f; general
procedure
A mixture of compound 1 (1.296 g, 2 mmol), LiH (0.064 g, 8 mmol)
and compound 2 (8 mmol) was stirred at 25 °C in DMF (60 mL) for
6 h under a N2 atmosphere. A few drops of methanol were added and
the reaction mixture was concentrated in vacuo. Water (100 mL) was
added to the residue and the crude product was precipitated. Recryst-
allisation from chloroform/methanol afforded the corresponding
di-O-arylmethyl-p-t-butylcalix[4]arenes 3d–f.
25,27-Bis(benzyloxy)-26,28-dihydroxy-p-t-butylcalix[4]arene (3d):
White needles; m.p. 234.3–236.8 °C; [lit.18 239–241 °C]; IR vmax
=
3395, 3285, 2958, 2866, 1484, 1362, 1205, 871, 781 cm−1; H NMR
(CDCl3) δ 7.64–7.61 (m, 4H, ArH), 7.35–7.33 (m, 6H, ArH), 7.28 (s,
2H, OH), 7.02 (s, 4H, ArH), 6.77 (s, 4H, ArH), 5.04 (s, 4H, OCH2Ar),
4.27 (d, J = 12.8 Hz, 4H, ArCH2Ar), 3.26 (d, J = 13.2 Hz, 4H,
ArCH2Ar), 1.28 (s, 18H, C(CH3)3), 0.94 (s, 18H, C(CH3)3); 13C NMR
(CDCl3) δ 150.6, 149.6, 146.8, 141.1, 137.0, 132.4, 128.5, 127.6,
127.5, 127.2, 125.3, 124.8, 77.9, 34.0, 33.9, 31.8, 31.6, 31.1; MS(ESI):
m/z (%) = 851 (M+ + Na, 100).
l
25,27-Bis(4-iodobenzyloxy)-26,28-dihydroxy-p-t-butylcalix[4]-
arene (3e): White needles; m.p. 248.8–250.4 °C; [lit.20 228–229 °C];
IR vmax = 3533, 3422, 3046, 2958, 2866, 1484, 1362, 1213, 872,
806 cm−1; lH NMR (CDCl3) δ 7.70 (d, J = 8.4 Hz, 4H, ArH), 7.39(d,
J = 8.0Hz, 4H, ArH), 7.14 (s, 2H, OH), 7.02 (s, 4H, ArH), 6.76 (s, 4H,
ArH), 4.97 (s, 4H, OCH2Ar), 4.21 (d, J = 13.2Hz, 4H, ArCH2Ar), 3.27
(d, J = 13.2Hz, 4H, ArCH2Ar), 1.28 (s, 18H, C(CH3)3), 0.93 (s, 18H,
C(CH3)3); 13C NMR (CDCl3) δ 150.1, 149.0, 146.7, 141.0, 137.2,
136.3, 132.0, 128.7, 127.1, 125.1, 124.6, 93.2, 76.8, 33.7, 33.6, 31.5,
31.4, 30.8; MS(ESI): m/z (%) = 1098 (M+ + NH4, 100).
25,27-Bis(4-methylbenzyloxy)-26,28-dihydroxy-p-t-butylcalix[4]-
arene (3f): White needles; m.p. 237.0–239.2 °C; IR vmax = 3418, 3047,
2952, 2864, 1483, 1361, 1198, 873, 781 cm−1; 1H NMR (CDCl3)
δ 7.50 (d, J = 8.0 Hz, 4H, ArH), 7.33 (s, 2H, OH), 7.15 (d, J = 7.6 Hz,
4H, ArH), 7.00 (s, 4H, ArH), 6.76 (s, 4H, ArH), 4.99 (s, 4H, OCH2Ar),
4.26 (d, J = 13.2 Hz, 4H, ArCH2Ar), 3.24 (d, J = 12.8 Hz, 4H,
ArCH2Ar), 2.40 (s, 6H, CH3), 1.28 (s, 18H, C(CH3)3), 0.94 (s, 18H,
C(CH3)3); 13C NMR (CDCl3) δ 150.6, 149.6, 146.7, 141.0, 137.1,
134.0, 132.5, 129.1, 127.6, 127.4, 125.3, 124.8, 77.9, 34.0, 33.9, 31.8,
31.1, 21.4; m/z (%) = 855 (M− – 1, 100); HRMS-ESI: Calcd for
C60H72NaO4 (M+Na)+: 879.5328; found: 879.5357.
Synthesis of tetra-O-arylmethyl-p-t-butylcalix[4]arenes 3j–l; general
procedure
A mixture of compound 1 (1.296 g, 2 mmol), Ba(OH)2·8H2O (1.575 g,
5 mmol), BaO (0.765 g, 5 mmol) and compound 2 (10 mmol) was
stirred at 25 °C in DMF (60 mL) for 3 h under a N2 atmosphere. The
reaction mixture was concentrated in vacuo. Water (100 mL) was
added to the residue and crude product was precipitated. Recrystalli-
sation from chloroform/methanol afforded the corresponding tetra-O-
arylmethyl-p-t-butylcalix[4]arenes 3j–l.
25,26,27,28-Tetrakis(benzyloxy)-p-t-butylcalix[4]arene (3j): White
needls; m.p. 237.7–239.9 °C; [lit.18 230–231 °C]; IR vmax = 3062,
l
2953, 2867, 1479, 1361, 1194, 870, 753 cm−1; H NMR (CDCl3)
δ 7.28–7.16 (m, 20H, ArH), 6.68 (s, 8H, ArH), 4.84 (s, 8H, OCH2Ar),
4.15 (d, J = 12.4 Hz, 4H, ArCH2Ar), 2.83 (d, J = 12.4 Hz, 4H,
ArCH2Ar), 1.05 (s, 36H, C(CH3)3); 13C NMR (CDCl3) δ 152.8, 144.5,
138.5, 134.0, 129.8, 128.1, 127.7, 125.1, 76.9, 34.2, 31.9; MS(ESI):
m/z (%) = 1031 (M+ + Na, 70), 940 (100).
Synthesis of tri-O-arylmethyl-p-t-butylcalix[4]arenes 3g–i; general
procedure
25,26,27,28-Tetrakis(4-iodobenzyloxy)-p-t-butylcalix[4]arene
(3k): White solid; m.p. 224.0–225.8 °C; IR vmax = 3060, 2958, 2866,
1480, 1193, 870, 791 cm−1; lH NMR(CDCl3) δ 7.50 (d, J = 8.0 Hz, 8H,
ArH), 6.93 (d, J = 7.6 Hz, 8H, ArH), 6.71 (s, 8H, ArH), 4.72 (s, 8H,
OCH2Ar), 4.08 (d, J = 12.8 Hz, 4H, ArCH2Ar), 2.88 (d, J = 12.4 Hz,
4H, ArCH2Ar), 1.06 (s, 36H, C(CH3)3); 13C NMR (CDCl3) δ 152.2,
144.7, 137.5, 137.0, 133.4, 131.1, 125.0, 93.5, 76.0, 33.9, 31.5;
MS(ESI): m/z (%) =1535 (M+ + Na, 87), 1536 (100); HRMS-ESI:
Calcd for C72H76I4KO4 (M+K)+: 1551.1559; found: 1551.1562.
25,26,27,28-Tetrakis(4-methylbenzyloxy)-p-t-butylcalix[4]arene
A mixture of compound 1 (1.296 g, 2 mmol), Ba(OH)2·8H2O (0.788 g,
2.5 mmol), BaO (0.383 g, 2.5 mmol) and compound 2 (6 mmol) was
stirred at 25 °C in DMF (50 mL) for 2.5 h under a N2 atmosphere.
The reaction mixture was concentrated in vacuo. Water (100 mL) was
added to the residue and the crude product was precipitated. Recryst-
allisation from chloroform/methanol afforded the corresponding
tri-O-arylmethyl-p-t-butylcalix[4]arenes 3g–i.
25,26,27-Tris(benzyloxy)-28-hydroxy-p-t-butylcalix[4]arene (3g):
White solid; m.p. 216.7–218.3 °C; [lit.21 210–214 °C]; IR vmax = 3549,
3455, 2954, 2866, 1481, 1362, 1197, 871, 752 cm−1; lH NMR (CDCl3)
(3l): White needls; m.p. 199.6–201.2 °C; [lit.18 205–207 °C]; IR vmax
=
1
3048, 2960, 2866, 1479, 1195, 869, 751 cm−1; H NMR (CDCl3) δ